Clinical Evidence

Dexcom is committed to providing healthcare professionals with the latest clinical evidence to demonstrate positive outcomes for Dexcom CGM. We’ve also included available professional society guidance and criteria that can help identify patients who could benefit from CGM technology.

Clinical Studies

Review Peer-reviewed evidence demonstrating the positive impact that CGM has on glycaemic control and variability.

Professional Society Guidelines

Professional societies continue to expand their recommendation of continuous glucose monitoring (CGM) use in patient care protocols for both adult and paediatric patients with type 1 diabetes. Based on the NHS funding criteria, it is estimated that up to 70% of patients with T1D may be eligible for Dexcom G6.(1)

(1) NHS Digital. National Diabetes Insulin Pump Audit (2017-18), 08 August 2019